Dr Alberto Hidalgo


Alberto Hidalgo graduated in Biology from Universidad Complutense de Madrid (Spain). Subsequently, he obtained an MBA in Biotechnology and Management and an MSc in Biochemistry, Molecular Biology and Biomedicine. After working as a consultant for pharmaceutical and biotechnological companies in Spain and the UK, he obtained his PhD from Universidad Complutense de Madrid in 2018. His research is focused on pulmonary drug delivery. He aims to create sophisticated lung models using the 3D bioprinting and lung-on-chip technologies to explore the potential use of pulmonary surfactant as a drug delivery system and set the basis of a new and non-invasive strategy: the Interfacial Therapy.